Immune Modulatory Oligonucleotides in the Prevention and Treatment of OVA-Induced Eustachian Tube Dysfunction in Rats

Abstract

BACKGROUND: Otitis media with effusion (OME) is often associated with allergies. Immune modulatory oligonucleotides (IMO) mediate allergic inflammation and may therefore be efficacious in the treatment of airway inflammation.

OBJECTIVE: To evaluate the role of an IMO via transtympanic mucosal application in prevention and treatment of ovalbumin-induced OME.

DESIGN: Forty brown Norway rats were divided into control and treatment groups. Eustachian tube dysfunction was evaluated by passive opening pressures, passive closing pressures, active clearance of negative pressure, and mucociliary clearance transit time.

RESULTS: Rats who underwent IMO treatment required 50% less pressure to open and close the eustachian tube (P < 0.05) and were able to actively clear 50% more negative pressure than the ovalbumin-control rats (P < 0.001). The treatment rats' mucociliary clearance time was half that of the control group (P < 0.001).

CONCLUSION: IMO via transtympanic application can prevent and treat allergy-induced eustachian tube dysfunction in rats. IMO may offer substantial promise in the future management of OME.

Get full access to this article

View all access options for this article.

References

Nguyen

Manoukian

Sobol

. Similar allergic inflammation in the middle ear and the upper airway: Evidence linking otitis media with effusion to the united airways concept. J Allergy Clin Immunol 2004;114:1110–5. (Grade B).

Bernstein

Role of allergy in eustachian tube blockage and otitis media with effusion: A review. Otolaryngol Head Neck Surg 1996;114:562–8. (Grade B).

Rosenfeld

Culpepper

Doyle

. Clinical practice guideline: Otitis media with effusion. Otolaryngol Head Neck Surg 2004;130:S95–118. (Grade A).

Bluestone

Hebda

Alper

. Recent advances in otitis media. 2. eustachian tube, middle ear, and mastoid anatomy; physiology, pathophysiology, and pathogenesis. Ann Otol Rhinol Laryngol Suppl 2005;194:16–30. (Grade B).

Lazo-Saenz

Galvan-Aguilera

Martinez-Ordaz

. Eustachian tube dysfunction in allergic rhinitis. Otolaryngol Head Neck Surg 2005;132:626–9. (Grade B).

Fireman

Otitis media and eustachian tube dysfunction: Connection to allergic rhinitis. J Allergy Clin Immunol 1997;99:S787–97. (Grade D).

Tewfik

Mazer

The links between allergy and otitis media with effusion. Curr Opin Otolaryngol Head Neck Surg 2006;14:187–90. (Grade B).

Kandimalla

Bhagat

. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists. Proc Natl Acad Sci USA 2005;102:6925–30. (Grade D).

Klinman

Use of CpG oligodeoxynucleotides as immunoprotective agents. Expert Opin Biol Ther 2004;4:937–46. (Grade D).

10.

Agrawal

Edwan

Kandimalla

. Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma. Int Immunopharmacol 2004;4:127–38. (Grade D).

11.

Zhu

Kandimalla

. Modulation of ovalbumin-induced Th2 responses by second-generation immunomodulatory oligonucleotides in mice. Int Immunopharmacol 2004;4:851–62. (Grade D).

12.

Ebert

Jr Rose

Patel

The role of immunomodulatory oligonucleotides in prevention of OVA-induced eustachian tube dysfunction. Int J Pediatr Otorhinolaryngol 2006. Per medline (Grade D).

13.

Kandimalla

Bhagat

Wang

. Divergent synthetic nucleotide motif recognition pattern: Design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction profiles. Nucleic Acids Res 2003;9:2393–400. (Grade D).

14.

Hardy

Heavner

White

. Late-phase allergy and eustachian tube dysfunction. Otolaryngol Head Neck Surg 2001;125:339–35. (Grade D).

15.

Flisberg

Ingelstedt

Ortegren

The valve and “locking” mechanisms of the eustachian tube. Acta Otolaryngol 1963;Suppl182:57–68. (Grade D).

16.

Banerjee

Kelly

Fink

. Modulation of airway inflammation by immunostimulatory CpG oligodeoxynucleotides in a murine model of allergic aspergillosis. Infect Immun 2004;72:6087–94. (Grade D).

17.

Takabayashi

Libet

Chisholm

. Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice. J Immunol 2003;170:3898–905. (Grade D).